Rima Isaifan | human health | Women Researcher Award

Assoc. Prof. Dr. Rima Isaifan | human health | Women Researcher Award

Associate Professor, Cambridge C University, Qatar

๐ŸŒฟ Dr. Rima Isaifan is an Associate Professor of Environmental Sciences at Cambridge Corporate University, Lucerne, Switzerland. With a Ph.D. in Chemical and Biological Engineering from the University of Ottawa, she has made significant contributions to the fields of sustainable development and environmental protection. Her extensive research focuses on climate change, greenhouse gas emissions, and sustainable urban development, particularly in the Middle Eastern context. ๐ŸŒ

Publication Profile

Scopus

Education

๐ŸŽ“ Dr. Isaifan earned her Ph.D. in Chemical Engineering (Chemical and Biological Engineering) from the University of Ottawa in 2014. Her academic background blends environmental and chemical sciences, making her an expert in sustainable environmental solutions.

Experience

๐Ÿ’ผ Currently an Associate Professor at Cambridge Corporate University, Switzerland, Dr. Isaifan has a wealth of teaching and research experience in environmental sciences. She has also collaborated with multiple research institutions, contributing her knowledge to various climate and sustainability initiatives in the Middle East.

Research Focus

๐Ÿ”ฌ Dr. Isaifan’s research revolves around environmental sustainability, climate change, and the social cost of greenhouse gas emissions. She has also explored urban development strategies, especially in the Middle East, focusing on sustainable transportation and urban renewal projects. Her work aims to create practical solutions to mitigate climate change. ๐ŸŒฑ

Awards and Honors

๐Ÿ… Dr. Isaifan’s outstanding contributions to environmental research and sustainability have earned her recognition in academic and professional communities. She continues to push boundaries in environmental policy and science, especially regarding climate change action in Arab countries. ๐ŸŒ

Publication Highlights

๐Ÿ“š Dr. Isaifan has published extensively in top-tier journals. Some of her notable works include:

Transit-Oriented Development in Middle Eastern Cities: The Urban Renewal Framework for the Souq Waqif in Doha, Qatar (2024) in Urban Science, DOI: 10.3390/urbansci8040182

Correction: Al-Jabir, M.; Isaifan, R.J. Long-Term Projection of Transport-Related Social Cost of Greenhouse Gas Emissions in Qatar (2024) in Sustainability, DOI: 10.3390/su16198422

Strategic plans to support action against climate change in the Arab countries in the Middle East Region (2024) in Journal of Sustainable Development Law and Policy, DOI: 10.4314/jsdlp.v15i1.11

Long-Term Projection of Transport-Related Social Cost of Greenhouse Gas Emissions in Qatar (2024) in Sustainability, DOI: 10.3390/su16020536

 

Chenjing Zhu | Oncology | Best Researcher Award

Dr. Chenjing Zhu | Oncology | Best Researcher Award

Associate professor, Jiangsu Cancer Hospital, China

Cenjing Zhu is a dedicated medical professional specializing in radiation oncology at Jiangsu Cancer Hospital, Nanjing, China. With a strong background in clinical research and cancer treatment, she has made significant contributions to understanding cancer biology and therapeutic strategies. Dr. Zhu has a keen interest in advancing medical science through research, education, and clinical excellence. ๐ŸŒŸ๐Ÿ’‰

Publication Profile

ORCID

Education

Dr. Zhu completed her Bachelor of Medicine (2011-2016) and M.D. (2016-2019) from the West China School of Medicine, Sichuan University, Chengdu, China. Her academic journey in the field of medicine has paved the way for her expertise in oncology and cancer research. ๐ŸŽ“๐Ÿ“š

Experience

Since 2019, Dr. Zhu has been a part of the Department of Radiation Oncology at Jiangsu Cancer Hospital, where she contributes to both clinical care and scientific research. Her leadership in cancer research and clinical innovation is well-recognized within the medical community. ๐Ÿฅ๐Ÿ’ผ

Research Focus

Dr. Zhu’s research primarily revolves around cancer therapeutics, focusing on the AXL receptor tyrosine kinase as an anti-cancer approach, psychological distress in cancer patients, and innovative diagnostic techniques in oncology. She is particularly interested in tumor microenvironment modulation and the application of advanced imaging techniques in cancer treatment. ๐Ÿ”ฌ๐Ÿงฌ

Awards and Honors

Throughout her career, Dr. Zhu has been invited to present her work at prestigious international conferences, including the World Congress on Advances in Oncology and the International Symposium on Molecular Medicine. Her research excellence has garnered recognition and invitations to prominent platforms for cancer research and molecular medicine. ๐Ÿ†๐ŸŒ

Publication Top Notes

Zhu’s influential article on AXL receptor tyrosine kinase as a promising anti-cancer approach, Molecular Cancer 2019, has reshaped clinical strategies, cited extensively.

Her 2020 study on dual MET/AXL inhibitors in gastric carcinoma, published in MedComm, offers groundbreaking insights into tumor microenvironment modulation.

Zhuโ€™s 2024 research in BMC Psychol on psychological distress in Chinese cancer patients demonstrates the importance of mental health during cancer treatment.

Her 2024 review of circulating microRNAs as diagnostic biomarkers for cervical cancer in Discov Oncol continues to shape diagnostic research in oncology

Bryson Kemler | Medicine and Dentistry | Best Researcher Award

Dr. Bryson Kemler | Medicine and Dentistry | Best Researcher Award

Orthopaedic Surgeon at Rothman Orthopaedic Institute, United States

Dr. Bryson R. Kemler, M.D., M.S., is an orthopedic surgeon specializing in sports medicine. He is currently a fellow at the prestigious Cedars-Sinai Kerlan-Jobe Orthopaedic Clinic in Los Angeles. With a focus on treating sports injuries, Dr. Kemler has worked extensively with professional athletes and university sports teams. His dedication to advancing orthopedic care is reflected in his prolific research and clinical practice, aimed at enhancing recovery and performance in sports medicine.

Profile

Scopus Profile

Education๐ŸŽ“๐Ÿ“˜

Dr. Kemler holds a Doctor of Medicine (M.D.) degree from Eastern Virginia Medical School (2019), where he also earned a Master of Science in Biomedical Sciences (2014). He completed his Bachelor of Science in Neuroscience at the College of William and Mary in 2013. Dr. Kemler will finish his orthopedic surgery residency at Thomas Jefferson University Hospital in Philadelphia by June 2024, solidifying his expertise in the field.

Experience๐ŸŒ๏ธโ€โ™‚๏ธ๐Ÿ’

Dr. Kemler has extensive experience in orthopedic surgery and sports medicine, currently serving as an assistant team physician for the Los Angeles Dodgers and Anaheim Ducks. He has held key research roles, including a fellowship at the Steadman Philippon Research Institute, and has provided medical coverage for various professional and collegiate teams. He has also been involved in teaching at both the undergraduate and medical levels, helping to shape the next generation of medical professionals.

Research Interest๐Ÿ”ฌ๐Ÿƒโ€โ™‚๏ธ

Dr. Kemlerโ€™s research primarily focuses on sports-related injuries, particularly in areas such as ulnar collateral ligament reconstruction, chronic exertional compartment syndrome, and anterior cruciate ligament (ACL) injuries. His goal is to improve surgical outcomes and rehabilitation processes for athletes, helping them return to peak performance faster and more effectively. He is also interested in the biomechanical aspects of sports injuries, further contributing to advancements in sports medicine.

Awards๐Ÿ†๐ŸŽ–๏ธ

Dr. Kemler has been recognized for his contributions to orthopedic research and clinical practice. He received the ON/AOSSM Education Scholarship in 2022 to present at the American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting. He was also awarded a Major League Baseball Research Grant for his work on the blood supply variations in the ulnar collateral ligament. His commitment to advancing sports medicine earned him a research fellowship at the Steadman Philippon Research Institute (2017-2018).

Publications

  1. Kemler BR, et al. “Return to Play after UCL Injury in Gymnasts.” Phys Sportsmed. In Press. DOI: 10.1080/00913847.2024
  2. Kemler BR, et al. “Analysis of Patients Who Undergo Index Arthroscopy With Biopsy but Not Implantation for Staged Chondrocyte Cell Transplantation.” Orthop J Sports Med. 2024. DOI: 10.1177/23259671241271705
  3. Kemler BR, et al. “Considerations for Revision Anterior Cruciate Ligament Reconstruction.” J Orthop. 2024. DOI: 10.1016/j.jor.2024.05.012
  4. Kemler BR, et al. “Evaluation of Failed ACL Reconstruction: An Updated Review.” Open Access J Sports Med. 2024. DOI: 10.2147/OAJSM.S427332
  5. Kemler BR, et al. “Rehabilitation and Return to Sport Criteria After Ulnar Collateral Ligament Reconstruction.” Am J Sports Med. 2022. DOI: 10.1177/03635465211033994

Conclusion๐Ÿ…โœจ

Dr. Bryson Kemler is a highly dedicated orthopedic surgeon whose work bridges both clinical practice and research in sports medicine. With a deep commitment to advancing treatment for sports-related injuries, his contributions have been acknowledged by numerous awards and publications. His expertise is shaping the future of orthopedic care for athletes, making him a strong candidate for any professional recognition or award in the field of sports medicine.